X-15522470-G-C

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The NM_203281.3(BMX):​c.635G>C​(p.Ser212Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000235 in 1,210,903 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 80 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.000080 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.00025 ( 0 hom. 80 hem. )

Consequence

BMX
NM_203281.3 missense

Scores

17

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.758
Variant links:
Genes affected
BMX (HGNC:1079): (BMX non-receptor tyrosine kinase) This gene encodes a non-receptor tyrosine kinase belonging to the Tec kinase family. The protein contains a PH-like domain, which mediates membrane targeting by binding to phosphatidylinositol 3,4,5-triphosphate (PIP3), and a SH2 domain that binds to tyrosine-phosphorylated proteins and functions in signal transduction. The protein is implicated in several signal transduction pathways including the Stat pathway, and regulates differentiation and tumorigenicity of several types of cancer cells. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2016]
ACE2 (HGNC:13557): (angiotensin converting enzyme 2) The protein encoded by this gene belongs to the angiotensin-converting enzyme family of dipeptidyl carboxydipeptidases and has considerable homology to human angiotensin 1 converting enzyme. This secreted protein catalyzes the cleavage of angiotensin I into angiotensin 1-9, and angiotensin II into the vasodilator angiotensin 1-7. ACE2 is known to be expressed in various human organs, and its organ- and cell-specific expression suggests that it may play a role in the regulation of cardiovascular and renal function, as well as fertility. In addition, the encoded protein is a functional receptor for the spike glycoprotein of the human coronavirus HCoV-NL63 and the human severe acute respiratory syndrome coronaviruses, SARS-CoV and SARS-CoV-2, the latter is the causative agent of coronavirus disease-2019 (COVID-19). Multiple splice variants have been found for this gene and the dACE2 (or MIRb-ACE2) splice variant has been found to be interferon inducible. [provided by RefSeq, Nov 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.036927342).
BP6
Variant X-15522470-G-C is Benign according to our data. Variant chrX-15522470-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 2367891.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Hemizygotes in GnomAdExome4 at 80 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BMXNM_203281.3 linkc.635G>C p.Ser212Thr missense_variant Exon 7 of 19 ENST00000348343.11 NP_975010.1 P51813

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BMXENST00000348343.11 linkc.635G>C p.Ser212Thr missense_variant Exon 7 of 19 1 NM_203281.3 ENSP00000308774.6 P51813

Frequencies

GnomAD3 genomes
AF:
0.0000798
AC:
9
AN:
112746
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000322
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000150
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000109
AC:
20
AN:
183081
AF XY:
0.000133
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000365
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000125
Gnomad NFE exome
AF:
0.000208
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000251
AC:
276
AN:
1098157
Hom.:
0
Cov.:
32
AF XY:
0.000220
AC XY:
80
AN XY:
363547
show subpopulations
African (AFR)
AF:
0.0000379
AC:
1
AN:
26396
American (AMR)
AF:
0.0000284
AC:
1
AN:
35193
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19383
East Asian (EAS)
AF:
0.0000331
AC:
1
AN:
30202
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54148
European-Finnish (FIN)
AF:
0.0000987
AC:
4
AN:
40531
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4136
European-Non Finnish (NFE)
AF:
0.000299
AC:
252
AN:
842079
Other (OTH)
AF:
0.000369
AC:
17
AN:
46089
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
13
26
38
51
64
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000798
AC:
9
AN:
112746
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
34914
show subpopulations
African (AFR)
AF:
0.0000322
AC:
1
AN:
31026
American (AMR)
AF:
0.00
AC:
0
AN:
10664
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2661
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3594
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2755
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6239
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
240
European-Non Finnish (NFE)
AF:
0.000150
AC:
8
AN:
53359
Other (OTH)
AF:
0.00
AC:
0
AN:
1522
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000904
Hom.:
1
Bravo
AF:
0.000110
ExAC
AF:
0.0000988
AC:
12
EpiCase
AF:
0.000437
EpiControl
AF:
0.000178

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Nov 07, 2022
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.060
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.76
CADD
Benign
0.24
DANN
Benign
0.21
DEOGEN2
Benign
0.11
T;T;T
FATHMM_MKL
Benign
0.0017
N
LIST_S2
Benign
0.19
.;.;T
M_CAP
Benign
0.0038
T
MetaRNN
Benign
0.037
T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.0
N;N;N
PhyloP100
-0.76
PrimateAI
Benign
0.40
T
PROVEAN
Benign
0.26
N;N;N
REVEL
Benign
0.074
Sift
Benign
0.63
T;T;T
Sift4G
Benign
0.57
T;T;T
Polyphen
0.14
B;B;B
Vest4
0.078
MVP
0.46
MPC
0.31
ClinPred
0.030
T
GERP RS
-0.47
Varity_R
0.15
gMVP
0.055
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147917241; hg19: chrX-15540593; API